JPH0450312B2 - - Google Patents
Info
- Publication number
- JPH0450312B2 JPH0450312B2 JP27607485A JP27607485A JPH0450312B2 JP H0450312 B2 JPH0450312 B2 JP H0450312B2 JP 27607485 A JP27607485 A JP 27607485A JP 27607485 A JP27607485 A JP 27607485A JP H0450312 B2 JPH0450312 B2 JP H0450312B2
- Authority
- JP
- Japan
- Prior art keywords
- bis
- ethane
- crystals
- ethanol
- reduced pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 239000013078 crystal Substances 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 8
- 230000000259 anti-tumor effect Effects 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- -1 dioxopiperazine compound Chemical class 0.000 description 7
- 239000000203 mixture Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 238000000921 elemental analysis Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- GBLIGNUYGOFIKS-UHFFFAOYSA-N 4-[2-(3,5-dioxopiperazin-1-yl)ethyl]piperazine-2,6-dione Chemical compound C1C(=O)NC(=O)CN1CCN1CC(=O)NC(=O)C1 GBLIGNUYGOFIKS-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 2
- 208000006268 Sarcoma 180 Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002927 anti-mitotic effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 230000007998 vessel formation Effects 0.000 description 2
- LPNZFNBNRWCBKA-UHFFFAOYSA-N 2,6-diethylmorpholine Chemical compound CCC1CNCC(CC)O1 LPNZFNBNRWCBKA-UHFFFAOYSA-N 0.000 description 1
- HNVIQLPOGUDBSU-UHFFFAOYSA-N 2,6-dimethylmorpholine Chemical compound CC1CNCC(C)O1 HNVIQLPOGUDBSU-UHFFFAOYSA-N 0.000 description 1
- RGNFMQJLAOONTP-UHFFFAOYSA-N 2-ethylmorpholine Chemical compound CCC1CNCCO1 RGNFMQJLAOONTP-UHFFFAOYSA-N 0.000 description 1
- LQMMFVPUIVBYII-UHFFFAOYSA-N 2-methylmorpholine Chemical compound CC1CNCCO1 LQMMFVPUIVBYII-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27607485A JPS62135472A (ja) | 1985-12-10 | 1985-12-10 | 新規な１，２−ビス−３，５−ジオキソピペラジニルエタン誘導体 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27607485A JPS62135472A (ja) | 1985-12-10 | 1985-12-10 | 新規な１，２−ビス−３，５−ジオキソピペラジニルエタン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62135472A JPS62135472A (ja) | 1987-06-18 |
| JPH0450312B2 true JPH0450312B2 (ko) | 1992-08-13 |
Family
ID=17564435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP27607485A Granted JPS62135472A (ja) | 1985-12-10 | 1985-12-10 | 新規な１，２−ビス−３，５−ジオキソピペラジニルエタン誘導体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62135472A (ko) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992000971A1 (en) * | 1990-07-04 | 1992-01-23 | Zenyaku Kogyo Kabushiki Kaisha | Water-soluble bis-dioxopiperazine derivative |
| US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
| US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
| US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
-
1985
- 1985-12-10 JP JP27607485A patent/JPS62135472A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62135472A (ja) | 1987-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH062740B2 (ja) | 医薬用組成物 | |
| JPH02138238A (ja) | ベンジリデン−およびシンナミリデン−マロンニトリル誘導体およびその製法 | |
| AU662800B2 (en) | Chelate complexes and processes for their preparation | |
| CN101195597A (zh) | 1-取代-4,4-二取代氨基硫脲类化合物、其制备方法以及其用途 | |
| CN107235916A (zh) | 一种具抗肿瘤活性的甘草查尔酮a硫脲嘧啶类衍生物及其合成方法 | |
| JPS62198666A (ja) | １−ベンジル−２−／ｎ−置換／−カルバモイル−テトラヒドロイソキノリン及びその製造方法 | |
| JPH0714877B2 (ja) | メタリセニウム塩および癌の治療における細胞増殖抑制剤としてのその使用 | |
| JPS5951537B2 (ja) | 新規α−アミノオキシカルボン酸ヒドラジド誘導体の製造法 | |
| JPH0450312B2 (ko) | ||
| CN108516969B (zh) | 喹啉缩氨基硫脲-吡啶有机化合物及其制备方法与应用 | |
| EP0013818A1 (en) | Organosilicon compounds, their preparation and anti-tumor agents containing the same | |
| PL128998B1 (en) | Process for preparing novel 2-amino-3-benzoylphenylacetamides and their derivatives | |
| US4293700A (en) | 2,6-Dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid esters and method for preparing same | |
| CN114656453A (zh) | 七甲川吲哚花菁-tempo化学偶链小分子和制备方法及其制备辐射防护制剂的应用 | |
| JPS62281860A (ja) | アルキレンアミノアルキレン ヘテロ原子基を有するジヒドロ−３，５−ジカルボキシレ−ト | |
| JPH01117885A (ja) | 新規ボドフィロトキシン誘導体及びその製造法 | |
| CA3191714A1 (en) | Benzylamine derivative, preparation method therefor and use thereof | |
| RU2678969C1 (ru) | Антиаритмическое средство на основе гибридной молекулы амлодипина с (7-метоксикумарин-4-ил)уксусной кислотой | |
| JPS63264580A (ja) | ３−（２−ハロアルキル）−１，４−オキサチインおよび２−（２−ハロアルキル）−１，４−ジチイン | |
| JPH0370700B2 (ko) | ||
| JPS6145989B2 (ko) | ||
| FR2837202A1 (fr) | Nouveaux derives de porphyrines, leur procede de preparation compositions pharmaceutiques et utilisations | |
| JPH01221364A (ja) | Ｈｉｖ逆転写酵素阻害剤および抗腫瘍剤 | |
| JPS6360929A (ja) | 抗腫瘍剤 | |
| US3948901A (en) | Bis (2,4-dioxotetrahydropyrimidinyl-5-sulphonoamido) diphenylsulphoner |